Hospital Infanta Leonor | Internal Medicine Department

Research site

(Unclaimed)

Location

Avenida del Este 50, Madrid, Madrid, Spain

Site insights

Top conditions

Top treatments

Emtricitabine

Lenalidomide

Velcade

Dexamethasone

Baricitinib

LY3009104

DRV

Secukinumab

Darunavir

Sildenafil

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 53 total trials

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

This study compares semaglutide, together with a lower dose of insulin glargine, to a higher dose of insulin glargine in participants with type 2 dia...

Active, not recruiting

Obesity

Diabetes Mellitus, Type 2

Drug: Insuline glargine U100 (titrated)

Drug: Insuline glargine U100 (reduced)

A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)

The main aim of this study is learn more about long-term TAK-503 treatment in children and teenagers with ADHD for whom earlier stimulant treatment d...

Active, not recruiting

Attention Deficit Hyperactivity Disorder

Drug: Guanfacine hydrochloride (TAK-503)

Other: Placebo

A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

The primary objective of this study is to evaluate if venetoclax when co administered with low-dose cytarabine (LDAC) improves overall survival (OS)...

Active, not recruiting

Acute Myeloid Leukemia (AML)

Drug: Placebo

Drug: Venetoclax

A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis (TRuE-AD4)

This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or a...

Enrolling

Atopic Dermatitis

Drug: Ruxolitinib Cream

Drug: Vehicle Cream

Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients

This is a multicenter, open label clinical trial evaluating the safety of the combination of belantamab mafodotin + the combination treatment VRd (bo...

Enrolling

Multiple Myeloma

Drug: Dexamethasone

Drug: Lenalidomide

Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) (BRUIN-MCL-321)

This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib (LOXO-30...

Active, not recruiting

Lymphoma, Mantle-Cell

Drug: Ibrutinib

Drug: Pirtobrutinib